Market Overview:
The global hospital acquired infections control market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of hospital-acquired infections (HAIs), rising demand for advanced diagnostic techniques, and growing awareness about HAIs among healthcare professionals and patients. In addition, the increasing number of mergers and acquisitions in the healthcare sector is also contributing to the growth of this market. On the basis of type, the global hospital acquired infections control market can be segmented into diagnostic techniques, cleaning and sterilization, and treatment. The diagnostic techniques segment is expected to grow at a CAGR of 8% from 2018 to 2030 due to technological advancements in this field such as next-generation sequencing (NGS) technology that helps in rapid diagnosis of HAIs.
Product Definition:
Hospital acquired infections control is the practice of preventing and controlling infections that are acquired by patients during their hospital stay. Hospital acquired infections (HAIs) are a major cause of death and illness in hospitals, and can be expensive to treat. The prevention of HAIs is therefore a priority for hospitals. There are many ways to prevent HAIs, including good hygiene practices, use of appropriate disinfectants, and screening patients for infection risk factors.
Diagnostic techniques:
Hospital-acquired infections (HAIs) are nosocomial infections that occur due to lack of sanitation and precaution in healthcare facilities. HAIs can be classified into two types: Healthcare-associated pneumonia (HCAIP), also known as ventilator associated pneumonia, is caused by the transmission of infection through a patient's airway or via another body fluid such as blood or urine.
Dleaning and sterilization:
Dusting and sterilization are the two most important equipment used in hospital acquired infections control market. DUST is a portable device that uses ultraviolet light to destroy microorganisms on surfaces. It is mostly used for cleaning medical devices, such as catheters, surgical instruments, IV tubes and other medical equipment which are suspected of being infected with bacteria or germs or viruses. The U.
Application Insights:
The general hospital segment held the largest market share of more than 60% in 2017. The need for proper cleaning and disinfection techniques to prevent the spread of infections has become critical in hospitals due to rising cases of hospital-acquired infections (HAIs). HAIs are also known asnosocomial infections which occur due to improper infection control practices during the course of treatment at a healthcare facility. These types ofinfections can be minimized by implementing guidelines provided by the Centers for Disease Control and Prevention (CDC)and other related government agencies.
According to a study published in NCBI, out of total 544 deaths caused by Hospital-Acquired Infections from 2000 - 2004, around 78% were reported from general hospitals while 22% were reported from infectious disease hospitals only; thus proving that there is an increased risk factor for acquiring these typesofinfections when admitted into a general hospital room as compared with an ICU or surgical ward room.
Regional Analysis:
North America dominated the global hospital acquired infections control market in 2017. This can be attributed to various factors such as favorable government initiatives, increasing awareness about patient safety, and presence of well-established healthcare facilities. Moreover, the implementation of effective infection control policies and procedures by hospitals is expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure in developing economies like India and China along with other South East Asian countries. In addition, growing medical tourism industry will also boost demand for HCITC services in this region over next eight years. Furthermore, economic development coupled with improvement in living standards has led people from middle income groups seeking treatment at hospitals located at prime locations across major cities worldwide; thereby driving demand for HCITC services in developed regions like Europe & North America as well as emerging regions including Asia Pacific & Middle East Africa (APMEA).
Growth Factors:
- Increasing incidence of hospital acquired infections (HAIs) due to the growing number of patients admitted in hospitals
- Growing awareness about HAIs and their prevention among healthcare professionals and patients alike
- Proliferation of new technologies for the diagnosis and treatment of HAIs
- Stringent government regulations to prevent the spread of HAIs in hospitals
- Increasing funding for research on novel methods to prevent or treat hospital acquired infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Hospital Acquired Infections Control Market Research Report
By Type
Diagnostic techniques, Dleaning and sterilization, Treatment
By Application
General Hospital, Infectious Disease Hospital
By Companies
Advanced Sterilization Products, Becton Dickinson, Belimed AG, bioMerieux, Cantel, Cepheid, Getinge, Merck & Co., Nordion, Pfizer, Roche, Sakura Seiki, Steris, TSO3
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Hospital Acquired Infections Control Market Report Segments:
The global Hospital Acquired Infections Control market is segmented on the basis of:
Types
Diagnostic techniques, Dleaning and sterilization, Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
General Hospital, Infectious Disease Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advanced Sterilization Products
- Becton Dickinson
- Belimed AG
- bioMerieux
- Cantel
- Cepheid
- Getinge
- Merck & Co.
- Nordion
- Pfizer
- Roche
- Sakura Seiki
- Steris
- TSO3
Highlights of The Hospital Acquired Infections Control Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic techniques
- Dleaning and sterilization
- Treatment
- By Application:
- General Hospital
- Infectious Disease Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hospital Acquired Infections Control Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hospital acquired infections (HAIs) are infections that occur in patients who are hospitalized. HAIs can be caused by a variety of bacteria, viruses, or fungi. They can lead to serious health problems and even death. Hospitals have a responsibility to take steps to prevent HAIs from occurring and to treat them if they do occur.
Some of the major players in the hospital acquired infections control market are Advanced Sterilization Products, Becton Dickinson, Belimed AG, bioMerieux, Cantel, Cepheid, Getinge, Merck & Co., Nordion, Pfizer, Roche, Sakura Seiki, Steris, TSO3.
The hospital acquired infections control market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hospital Acquired Infections Control Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hospital Acquired Infections Control Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hospital Acquired Infections Control Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hospital Acquired Infections Control Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hospital Acquired Infections Control Market Size & Forecast, 2020-2028
4.5.1 Hospital Acquired Infections Control Market Size and Y-o-Y Growth
4.5.2 Hospital Acquired Infections Control Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnostic techniques
5.2.2 Dleaning and sterilization
5.2.3 Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 General Hospital
6.2.2 Infectious Disease Hospital
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hospital Acquired Infections Control Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hospital Acquired Infections Control Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnostic techniques
9.6.2 Dleaning and sterilization
9.6.3 Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 General Hospital
9.10.2 Infectious Disease Hospital
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnostic techniques
10.6.2 Dleaning and sterilization
10.6.3 Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 General Hospital
10.10.2 Infectious Disease Hospital
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnostic techniques
11.6.2 Dleaning and sterilization
11.6.3 Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 General Hospital
11.10.2 Infectious Disease Hospital
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnostic techniques
12.6.2 Dleaning and sterilization
12.6.3 Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 General Hospital
12.10.2 Infectious Disease Hospital
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnostic techniques
13.6.2 Dleaning and sterilization
13.6.3 Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 General Hospital
13.10.2 Infectious Disease Hospital
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hospital Acquired Infections Control Market: Competitive Dashboard
14.2 Global Hospital Acquired Infections Control Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advanced Sterilization Products
14.3.2 Becton Dickinson
14.3.3 Belimed AG
14.3.4 bioMerieux
14.3.5 Cantel
14.3.6 Cepheid
14.3.7 Getinge
14.3.8 Merck & Co.
14.3.9 Nordion
14.3.10 Pfizer
14.3.11 Roche
14.3.12 Sakura Seiki
14.3.13 Steris
14.3.14 TSO3
